The effect of some antineoplastic agents on glutathione S-transferase from human erythrocytes

References

• Tozkoparan B, Aytaç SP. Kanser Kemoterapisinde Terapötik Hedef Olarak Glutatyon S-Transferazlar. Hacettepe Üniv Eczacılık Fak Dergisi 2007;27:139–164.
   Google Scholar
• Gaté L, Tew KD. Glutathione S-transferases as emerging therapeutic targets. Expert Opin Ther Targets 2001;5:477–489.
   PubMedGoogle Scholar
• Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983;52:711–760.
   PubMed Web of Science ®Google Scholar
• Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313–4320.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445–600.
   PubMed Web of Science ®Google Scholar
• Armstrong RN. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 1997;10:2–18.
   PubMed Web of Science ®Google Scholar
• Buetler TM, Eaton DL. Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues. Cancer Res 1992;52:314–318.
   PubMed Web of Science ®Google Scholar
• Pemble SE, Wardle AF, Taylor JB. Glutathione S-transferase class Kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J 1996;319 (Pt 3):749–754.
   PubMed Web of Science ®Google Scholar
• Board PG, Baker RT, Chelvanayagam G, Jermiin LS. Zeta, a novel class of glutathione transferases in a range of species from plants to humans. Biochem J 1997;328 (Pt 3):929–935.
   PubMed Web of Science ®Google Scholar
• Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, Schulte GK et al. Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem 2000;275:24798–24806.
   PubMed Web of Science ®Google Scholar
• Tidefelt U, Elmhorn-Rosenborg A, Paul C, Hao XY, Mannervik B, Eriksson LC. Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res 1992;52:3281–3285.
   PubMed Web of Science ®Google Scholar
• Green JA, Robertson LJ, Clark AH. Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer 1993;68:235–239.
   PubMed Web of Science ®Google Scholar
• Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 1993;11:49–58.
   PubMed Web of Science ®Google Scholar
• Grignon DJ, Abdel-Malak M, Mertens WC, Sakr WA, Shepherd RR. Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation. Mod Pathol 1994;7:186–189.
   PubMed Web of Science ®Google Scholar
• O’Brien ML, Tew KD. Glutathione and related enzymes in multidrug resistance. Eur J Cancer 1996;32A:967–978.
   PubMed Web of Science ®Google Scholar
• Tew KD, Dutta S, Schultz M. Inhibitors of glutathione S-transferases as therapeutic agents. Adv Drug Deliv Rev 1997;26:91–104.
   PubMed Web of Science ®Google Scholar
• Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369–7375.
   PubMed Web of Science ®Google Scholar
• Mahajan S, Atkins WM. The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cell Mol Life Sci 2005;62:1221–1233.
   PubMed Web of Science ®Google Scholar
• Zhao G, Wang X. Advance in antitumor agents targeting glutathione-S-transferase. Curr Med Chem 2006;13:1461–1471.
   PubMed Web of Science ®Google Scholar
• Beutler E. Red cell metabolism. A manual of biochemical methods, Grune and Stratton Inc., 3nd Ed.,Orlando, 1984.
   Google Scholar
• Toribio F, Martínez-Lara E, Pascual P, López-Barea J. Methods for purification of glutathione peroxidase and related enzymes. J Chromatogr B, Biomed Appl 1996;684:77–97.
   PubMed Web of Science ®Google Scholar
• Simons PC, Vander Jagt DL. Purification of glutathione S-transferases by glutathione-affinity chromatography. Meth Enzymol 1981;77:235–237.
   PubMedGoogle Scholar
• Habig WH, Jakoby WB. Assays for differentiation of glutathione S-transferases. Meth Enzymol 1981;77:398–405.
   PubMedGoogle Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–251.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
   PubMed Web of Science ®Google Scholar
• Lineweaver H, Burk D. The determination of enzyme dissociation constant. J American Chem Soc 1934;56:658–666.
   Web of Science ®Google Scholar
• Damia G, D’Incalci M. Mechanisms of resistance to alkylating agents. Cytotechnology 1998;27:165–173.
   PubMed Web of Science ®Google Scholar
• Colvin OM, Friedman HS, Gamcsik MP, Fenselau C, Hilton J. Role of glutathione in cellular resistance to alkylating agents. Adv Enzyme Regul 1993;33:19–26.
   PubMedGoogle Scholar
• Smith MT, Evans CG, Doane-Setzer P, Castro VM, Tahir MK, Mannervik B. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res 1989;49:2621–2625.
   PubMed Web of Science ®Google Scholar
• Waxman DJ. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy–a review. Cancer Res 1990;50:6449–6454.
   PubMed Web of Science ®Google Scholar
• Tsuchida S, Sato K. Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 1992;27:337–384.
   PubMed Web of Science ®Google Scholar
• Bredel M. Anticancer drug resistance in primary human brain tumors. Brain Res Brain Res Rev 2001;35:161–204.
   PubMed Web of Science ®Google Scholar
• Burg D, Filippov DV, Hermanns R, van der Marel GA, van Boom JH, Mulder GJ. Peptidomimetic glutathione analogues as novel gammaGT stable GST inhibitors. Bioorg Med Chem 2002;10:195–205.
   PubMed Web of Science ®Google Scholar
• Lyttle MH, Hocker MD, Hui HC, Caldwell CG, Aaron DT, Engqvist-Goldstein A et al. Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis. J Med Chem 1994;37:189–194.
   PubMed Web of Science ®Google Scholar
• O’Brien ML, Vulevic B, Freer S, Boyd J, Shen H, Tew KD. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. J Pharmacol Exp Ther 1999;291:1348–1355.
   PubMed Web of Science ®Google Scholar
• van Zanden JJ, Geraets L, Wortelboer HM, van Bladeren PJ, Rietjens IM, Cnubben NH. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol 2004;67:1607–1617.
   PubMed Web of Science ®Google Scholar
• Lyon RP, Hill JJ, Atkins WM. Novel class of bivalent glutathione S-transferase inhibitors. Biochemistry 2003;42:10418–10428.
   PubMed Web of Science ®Google Scholar
• Van Haaften RI, Evelo CT, Penders J, Eijnwachter MP, Haenen GR, Bast A. Inhibition of human glutathione S-transferase P1-1 by tocopherols and alpha-tocopherol derivatives. Biochim Biophys Acta 2001;1548:23–28.
   PubMed Web of Science ®Google Scholar
• Wu Z, Minhas GS, Wen D, Jiang H, Chen K, Zimniak P et al. Design, synthesis, and structure-activity relationships of haloenol lactones: site-directed and isozyme-selective glutathione S-transferase inhibitors. J Med Chem 2004;47:3282–3294.
   PubMed Web of Science ®Google Scholar
• Turella P, Cerella C, Filomeni G, Bullo A, De Maria F, Ghibelli L et al. Proapoptotic activity of new glutathione S-transferase inhibitors. Cancer Res 2005;65:3751–3761.
   PubMed Web of Science ®Google Scholar
• Güvercin S, Erat M, Sakiroglu H. Determination of some kinetic and characteristic properties of glutathione S-transferase from bovine erythrocytes. Protein Pept Lett 2008;15:6–12.
   PubMed Web of Science ®Google Scholar
• Smoter M, Bodnar L, Duchnowska R, Stec R, Grala B, Szczylik C. The role of Tau protein in resistance to paclitaxel. Cancer Chemother Pharmacol 2011;68:553–557.
   PubMed Web of Science ®Google Scholar
• Sato J, Kimura T, Saito T, Anazawa T, Kenjo A, Sato Y et al. Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2011;18:700–711.
   PubMed Web of Science ®Google Scholar
• Anderson CD, Pinson CW, Berlin J, Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004;9:43–57.
   PubMed Web of Science ®Google Scholar